市場調查報告書

糖尿病性胃輕癱治療的全球市場 - 市場規模,佔有率,預測,機會分析

Diabetic Gastroparesis Treatment Market: By Product Type, By Disease Indication, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

出版商 Coherent Market Insights 商品編碼 931849
出版日期 內容資訊 英文 171 Pages
商品交期: 2-3個工作天內
價格
糖尿病性胃輕癱治療的全球市場 - 市場規模,佔有率,預測,機會分析 Diabetic Gastroparesis Treatment Market: By Product Type, By Disease Indication, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
出版日期: 2020年03月05日內容資訊: 英文 171 Pages
簡介

糖尿病性胃輕癱,伴隨糖尿病相關的消化器官系統的問題。慢性糖尿病,阻礙各種內臟器官和含有迷走神經的神經系統的功能。迷走神經,控制排空胃的活動或排空胃的時間長度,即快或慢。損傷的迷走神經給予消化的影響,是食物在體內的殘留量超出需要。這個狀態被稱作胃輕癱,好發於第一型糖尿病,不過,第二型糖尿病的患者也會發病。根據鼻腔用噴霧等新治療選擇的調查開發,在預測期間內預計促進市場成長。另一方面,由於處方藥的改善相關臨床性證據的缺乏,臨床試驗的中止/結束等要素,預計妨礙市場成長。

本報告提供全球糖尿病性胃輕癱市場相關調查分析,市場概要,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 調查的目的與前提條件

    • 調查目的
    • 前提條件
    • 簡稱

第2章 市場展望

    • 報告概要
  • 市場定義和範圍
    • 摘要整理
  • 各產品類型市場
  • 各疾病症狀市場
  • 各流通管道市場
    • Coherent Opportunity Map(COM)

第3章 市場動態,法規,趨勢分析

    • 市場動態
  • 促進因素
  • 阻礙因素
  • 市場機會
    • 影響分析
    • 主要趨勢
    • 法規方案
    • PEST分析

第4章 全球糖尿病性胃輕癱治療市場: 各產品類型,2019年∼2027年(百萬美元)

    • 簡介
  • 市場佔有率分析,2019年及2027年(%)
  • 與前一年同期比較成長率分析,2017年∼2027年
  • 市場區隔趨勢
    • 藥物
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長率,2016年∼2027年(百萬美元)
  • 市場區隔趨勢
    • 胃運動促進藥
    • 制吐劑
    • 肉毒桿菌
    • 外科治療產品
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長率,2016年∼2027年(百萬美元)
  • 市場區隔趨勢
    • 胃的電刺激(GES)設備
    • 經皮內視鏡下胃瘺造設術(PEG)套件
    • 非口服營養

第5章 全球糖尿病性胃輕癱治療市場:各疾病症狀,2019年∼2027年(百萬美元)

    • 簡介
  • 市場佔有率分析,2019年及2027年(%)
  • 與前一年同期比較成長率分析,2017年∼2027年
  • 市場區隔趨勢
    • 補償性胃輕癱
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長率,2016年∼2027年(百萬美元)
    • 胃不全
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長率,2016年∼2027年(百萬美元)

第6章 全球糖尿病性胃輕癱治療市場:各流通管道,2019年∼2027年(百萬美元)

    • 簡介
  • 市場佔有率分析,2019年及2027年(%)
  • 與前一年同期比較成長率分析,2017年∼2027年
  • 市場區隔趨勢
    • 醫院藥局
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長率,2016年∼2027年(百萬美元)
    • 零售藥局
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長率,2016年∼2027年(百萬美元)
    • 線上藥局
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長率,2016年∼2027年(百萬美元)

第7章 全球糖尿病性胃輕癱治療市場:各地區,2019年∼2027年(百萬美元)

    • 簡介
  • 市場佔有率分析,2019年及2027年(%)
  • 與前一年同期比較成長率分析,2017年∼2027年
  • 市場區隔趨勢
    • 北美
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長率,2016年∼2027年(百萬美元)
    • 美國
    • 加拿大
    • 歐洲
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長率,2016年∼2027年(百萬美元)
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
    • 亞太地區
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長率,2016年∼2027年(百萬美元)
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太地區
    • 南美
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長率,2016年∼2027年(百萬美元)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他南美國家
    • 中東
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長率,2016年∼2027年(百萬美元)
    • GCC
    • 以色列
    • 其他中東
    • 非洲
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長率,2016年∼2027年(百萬美元)
    • 北非
    • 中非
    • 南非

第8章 競爭情形

    • 企業簡介
  • Janssen Global Services, LLC
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
  • Cardinal Health,Inc.
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
  • Evoke Pharma,Inc.
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
  • Salix Pharmaceuticals,Inc.
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
  • Alfa Wassermann SPA
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
  • Abbott Laboratories
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
  • Medtronic Plc.
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
  • C. R. Bard, Inc. (Becton, Dickinson and Company)
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
  • Rhythm Pharmaceuticals, Inc.
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
  • Boston Scientific Corporation
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
  • Kimberly-Clark Corporation
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
  • Vanda Pharmaceuticals, Inc.
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略
  • Allergan, plc.
    • 公司概要
    • 產品系列
    • 主要趨勢
    • 財務成果
    • 策略

第9章 Section

    • 參考文獻
    • 調查方法
    • 聯絡處
目錄

Diabetic gastroparesis involves digestive system issue associated with diabetes. Chronic Diabetes hampers functioning of various organs, and nervous system including vagus nerve. Vagus nerve controls stomach emptying activity or the time duration for stomach emptying i.e. how quick or slow. Damaged vagus serve affects digestion, and food stays for longer time in the body than required. This condition is called as gastroparesis, and is more common in people with type 1 diabetes, though type 2 diabetes patients can also get it. Research and development of newer treatment options such as nasal sprays is expected to support growth of the market over the forecast period. For instance, on 27 January 2020, Evoke Pharma, Inc., received Notice of Allowance for the Gimoti trademark from United States Patent and Trademark Office (USPTO). Gimoti is a nasal spray product candidate for the relief of symptoms in adult women with acute and recurrent diabetic gastroparesis. It is currently under review process for New Drug Disease Indication (NDA) by U.S. FDA and has a target Prescription Drug User Fee Act (PDUFA) of June 19, 2020.

Restraints of the Global Diabetic Gastroparesis Treatment Market

Factors such as lack of clinical evidence on improvement offered by prescription drugs, withdrawal/termination of clinical trials is also expected to hamper growth of the market.

Key features of the study:

This report provides in-depth analysis of the global diabetic gastroparesis treatment market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players

It profiles leading players in the global diabetic gastroparesis treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans

Key companies covered as a part of this study include Janssen Global Services, LLC, Cardinal Health, Inc., Evoke Pharma, Inc., Salix Pharmaceuticals, Inc., Alfa Wassermann SPA, Abbott Laboratories, Medtronic Plc., C. R. Bard, Inc. (Becton, Dickinson and Company), Rhythm Pharmaceuticals, Inc., Boston Scientific Corporation, Kimberly-Clark Corporation, Vanda Pharmaceuticals, Inc., and Allergan, plc.

Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics

The global diabetic gastroparesis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Diabetic Gastroparesis Treatment Market, By Product Type:

Drugs

Gastroprokinetic Agents

Antiemetic Agents

Botulinum Toxin

Surgical Treatment Products

Gastric Electrical Stimulation (GES) Device

Percutaneous Endoscopic Gastrostomy (PEG) Kit

Parenteral Nutrition

Global Diabetic Gastroparesis Treatment Market, By Disease Indication:

Compensated Gastroparesis

Gastric Failure

Global Diabetic Gastroparesis Treatment Market, By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Global Diabetic Gastroparesis Treatment Market, By Geography:

North America

By Product Type

Drugs

Gastroprokinetic Agents

Antiemetic Agents

Botulinum Toxin

Surgical Treatment Products

Gastric Electrical Stimulation (GES) Device

Percutaneous Endoscopic Gastrostomy (PEG) Kit

Parenteral Nutrition

By Disease Indication

Compensated Gastroparesis

Gastric Failure

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Country:

U.S.

Canada

Europe

By Product Type

Drugs

Gastroprokinetic Agents

Antiemetic Agents

Botulinum Toxin

Surgical Treatment Products

Gastric Electrical Stimulation (GES) Device

Percutaneous Endoscopic Gastrostomy (PEG) Kit

Parenteral Nutrition

By Disease Indication

Compensated Gastroparesis

Gastric Failure

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Country:

U.K.

Germany

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

By Product Type

Drugs

Gastroprokinetic Agents

Antiemetic Agents

Botulinum Toxin

Surgical Treatment Products

Gastric Electrical Stimulation (GES) Device

Percutaneous Endoscopic Gastrostomy (PEG) Kit

Parenteral Nutrition

By Disease Indication

Compensated Gastroparesis

Gastric Failure

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Country:

China

India

Japan

ASEAN

Australia

South Korea

Rest of Asia Pacific

Latin America

By Product Type

Drugs

Gastroprokinetic Agents

Antiemetic Agents

Botulinum Toxin

Surgical Treatment Products

Gastric Electrical Stimulation (GES) Device

Percutaneous Endoscopic Gastrostomy (PEG) Kit

Parenteral Nutrition

By Disease Indication

Compensated Gastroparesis

Gastric Failure

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Middle East:

By Product Type

Drugs

Gastroprokinetic Agents

Antiemetic Agents

Botulinum Toxin

Surgical Treatment Products

Gastric Electrical Stimulation (GES) Device

Percutaneous Endoscopic Gastrostomy (PEG) Kit

Parenteral Nutrition

By Disease Indication

Compensated Gastroparesis

Gastric Failure

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Country:

GCC

Israel

Rest of Middle East

Africa

By Product Type

Drugs

Gastroprokinetic Agents

Antiemetic Agents

Botulinum Toxin

Surgical Treatment Products

Gastric Electrical Stimulation (GES) Device

Percutaneous Endoscopic Gastrostomy (PEG) Kit

Parenteral Nutrition

By Disease Indication

Compensated Gastroparesis

Gastric Failure

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Country/Region:

Central Africa

South Africa

North Africa

Company Profiles

Janssen Global Services, LLC *

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

Cardinal Health, Inc.

Evoke Pharma, Inc.

Salix Pharmaceuticals, Inc.

Alfa Wassermann SPA

Abbott Laboratories

Medtronic Plc.

C. R. Bard, Inc. (Becton, Dickinson and Company)

Rhythm Pharmaceuticals, Inc.

Boston Scientific Corporation

Kimberly-Clark Corporation

Vanda Pharmaceuticals, Inc.

Allergan, plc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
  • Market Definition and Scope
    • Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Disease Indication
  • Market Snippet, By Distribution Channel
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis

4. Global Diabetic Gastroparesis Treatment Market, By Product Type, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Gastroprokinetic Agents
    • Antiemetic Agents
    • Botulinum Toxin
    • Surgical Treatment Products
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Gastric Electrical Stimulation (GES) Device
    • Percutaneous Endoscopic Gastrostomy (PEG) Kit
    • Parenteral Nutrition

5. Global Diabetic Gastroparesis Treatment Market, By Disease Indication, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Compensated Gastroparesis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Gastric Failure
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Diabetic Gastroparesis Treatment Market, By Distribution Channel, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Diabetic Gastroparesis Treatment Market, By Regions, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

    • Company Profiles
  • Janssen Global Services, LLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cardinal Health, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Evoke Pharma, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Salix Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Alfa Wassermann SPA
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic Plc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • C. R. Bard, Inc. (Becton, Dickinson and Company)
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Rhythm Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Kimberly-Clark Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vanda Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Allergan, plc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

    • References
    • Research Methodology
    • About us and Sales Contact